The HydroPeptide Shikimic Acid Peel is a professional exfoliation treatment designed to support visible skin renewal while maintaining comfort and barrier balance. This peel delivers controlled resurfacing using a carefully calibrated blend of exfoliating acids and skin supportive peptides, making it suitable for clients seeking refinement without excessive irritation.

The formulation combines shikimic, lactic, mandelic, and glycolic acids, selected for their complementary exfoliation profiles. Together, these acids assist in loosening surface cell buildup, refining skin texture, and promoting a clearer, more even looking complexion. The blend is designed to target congestion, uneven tone, and early signs of ageing while allowing for a controlled depth of exfoliation.

A patented peptide complex, CellRenew-16, is incorporated to support skin resilience and hydration during the exfoliation process. This helps maintain skin comfort and reduce the dryness often associated with more active peel formulations. St John’s wort extract, a botanical antioxidant with soothing properties, is included to help calm the skin and support recovery following treatment.

Prior to treatment, the skin is assessed to determine suitability and appropriate treatment planning. Application is performed in a controlled and monitored manner to prioritise safety and comfort. This treatment is classified as mild to moderate in intensity and is generally well tolerated, with minimal disruption to daily activities.

The HydroPeptide Shikimic Acid Peel may be performed as a standalone treatment or incorporated into a structured skin program. A course of treatments at regular intervals may be recommended to support gradual improvements in skin clarity, tone, and texture.

The HydroPeptide Shikimic Acid Peel is provided as a cosmetic skin treatment and is not intended to diagnose, treat, cure, or prevent any medical condition. Individual responses may vary. All treatments are performed following professional consultation and in accordance with manufacturer guidelines.

Contra Indications

This treatment is not suitable during pregnancy or nursing, aspirin allergy, nut allergy (bitter almond), sunburn, active acne lesions, rosacea, compromised skin barriers, or those currently using isotretinoin (Roaccutane). Suitability must be confirmed during consultation.

Post-Treatment Care Disclaimer:

Mild redness, dryness, or sensitivity may occur following treatment. Clients are advised to follow all post-treatment instructions provided by the clinic, including sun protection and appropriate home care. Results and recovery times vary between individuals. This treatment is not a substitute for medical advice or treatment.